Related Experiment Videos
Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an
1Department of Biological Sciences, Murray State University, KY 42071.
Abstract:
Mice were vaccinated with a temperature-sensitive, M-negative mutant (JC3) of Streptococcus pyogenes. This vaccine was found to offer protection from a lethal challenge of homologous M-negative and type 28 M-positive strains of S. pyogenes as well as heterologous M3 and M18 strains. Using an immunoblot method, hyperimmune serum from mice vaccinated with JC3 was found to contain moderate to high titres of antibody to all challenge strains. Additionally, this hyperimmune serum was used to probe Western blots of whole-cell proteins extracted from each of the above streptococcal strains. Three proteins were identified (M(r) = 32, 43 and 46 kDa) as immunogenic and conserved among the three serotypes studied.
Insights
A novel Streptococcus pyogenes vaccine (JC3) protected mice against lethal infections. This M-negative mutant vaccine induced antibodies targeting conserved M proteins across multiple S. pyogenes strains.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Streptococcus pyogenes (group A Streptococcus) causes various human infections.
- Developing a broadly protective vaccine against S. pyogenes remains a challenge due to serotype diversity.
- M protein is a key virulence factor and a target for vaccine development.
Purpose of the Study:
- To evaluate the protective efficacy of a temperature-sensitive, M-negative mutant (JC3) of S. pyogenes as a vaccine.
- To determine the breadth of protection against homologous and heterologous S. pyogenes strains.
- To identify immunogenic and conserved proteins elicited by the JC3 vaccine.
Main Methods:
- Mice were vaccinated with the JC3 S. pyogenes strain.
- Vaccinated mice were challenged with lethal doses of homologous (M-negative, M28) and heterologous (M3, M18) S. pyogenes strains.
- Hyperimmune serum from vaccinated mice was analyzed using immunoblot and Western blot techniques.
- Proteins recognized by the hyperimmune serum were identified based on their molecular weight.
Main Results:
- The JC3 vaccine conferred significant protection against lethal challenge with homologous and heterologous S. pyogenes strains.
- Hyperimmune serum from JC3-vaccinated mice showed moderate to high antibody titers against all tested challenge strains.
- Western blot analysis identified three conserved immunogenic proteins (32, 43, and 46 kDa) in S. pyogenes.
Conclusions:
- The temperature-sensitive, M-negative mutant JC3 of S. pyogenes is a promising vaccine candidate.
- JC3 vaccination induces a broad antibody response capable of neutralizing diverse S. pyogenes strains.
- Conserved immunogenic proteins identified could serve as targets for future vaccine development against S. pyogenes.